Cardinal Health adds new $1.0B 364-day credit line

Cardinal Health, Inc. entered into a new 364-day credit agreement on October 7, 2025 with Bank of America, N.A. as administrative agent and a syndicate of lenders.

Rhea-AI Filing Summary

Cardinal Health, Inc. entered into a new 364-day credit agreement on October 7, 2025 with Bank of America, N.A. as administrative agent and a syndicate of lenders. The facility provides access to up to $1.0 billion of revolving credit through October 6, 2026 and replaces a similar 364-day agreement that expired from October 2024.

At the termination date, Cardinal Health may, subject to conditions in the agreement, convert any outstanding borrowings into non-revolving term loans that must be repaid one year later. The agreement includes customary representations, covenants and events of default, including a financial covenant requiring a consolidated net leverage ratio not greater than 3.75 to 1.00 as of the last day of any fiscal quarter.

The revolving credit facility may be used for general corporate purposes and backs the company’s commercial paper program. Participating financial institutions and their affiliates have previously provided, and may continue to provide, various banking and financial services to Cardinal Health for customary fees.

8-K Event Classification

2 items: 1.01, 9.01

2 items

Item 1.01 Entry into a Material Definitive Agreement Business

The company signed a significant contract such as a merger agreement, credit facility, or major partnership.

Item 9.01 Financial Statements and Exhibits Exhibits

Financial statements, pro forma financial information, or exhibit attachments filed with this report.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What new credit facility did Cardinal Health (CAH) enter into in October 2025?

Cardinal Health entered into a new 364-day Credit Agreement on October 7, 2025, providing access to up to $1.0 billion of revolving credit through October 6, 2026.

Why did Cardinal Health (CAH) enter into this 364-day Credit Agreement?

Cardinal Health entered into the new 364-day Credit Agreement following the expiration of a similar 364-day credit agreement it entered into in October 2024, effectively renewing short-term revolving credit capacity.

What are the key terms of Cardinal Health’s (CAH) new $1.0 billion credit facility?

The facility provides up to $1.0 billion in revolving credit through October 6, 2026. Subject to conditions, Cardinal Health may convert any loans outstanding on that date into non-revolving term loans, repayable one year after the termination date.

What financial covenant is included in Cardinal Health’s (CAH) new credit agreement?

The agreement requires Cardinal Health to maintain a Consolidated Net Leverage Ratio of no greater than 3.75 to 1.00 as of the last day of any fiscal quarter, as defined in the agreement.

How can Cardinal Health (CAH) use the new 364-day revolving credit facility?

The revolving credit facility may be used for general corporate purposes and also backs Cardinal Health’s commercial paper program.

Who is the administrative agent under Cardinal Health’s (CAH) 364-day Credit Agreement?

Bank of America, N.A. serves as the Administrative Agent under the 364-day Credit Agreement, with various financial institutions as lenders.

Where can investors find the full terms of Cardinal Health’s (CAH) new credit agreement?

The full terms are included in Exhibit 10.1 to the report, titled “364-Day Credit Agreement, dated October 7, 2025.”

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding 8-K Material Events →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 10/10/2025 - 06:33 AM Learn about SEC filing dates

0000721371false00007213712025-09-302025-09-30

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

Current Report

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): October 7, 2025

Cardinal Health, Inc.

(Exact name of registrant as specified in its charter)

Ohio

1-11373

31-0958666

(State or other jurisdiction of incorporation)

(Commission File Number)

(IRS Employer Identification No.)

7000 Cardinal Place, Dublin, Ohio 43017

(614) 757-5000

(Registrant’s telephone number, including area code)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instructions A.2. below):

☐			Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐			Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐			Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐			Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:
Title of each class			Trading Symbol(s)			Name of each exchange on which registered
Common shares (without par value)			CAH			New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company  ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.   p

Item 1.01 Entry Into A Material Definitive Agreement

On October 7, 2025, Cardinal Health, Inc. (the “Company”), Bank of America, N.A., as Administrative Agent and each lender from time to time party thereto entered into a 364-Day Credit Agreement (the “Credit Agreement”). This Company entered into the Credit Agreement following the expiration of the 364-Day Credit Agreement into which it entered in October, 2024.

The Credit Agreement, among other things, allows the Company access to $1.0 billion of revolving credit through October 6, 2026 (the “Termination Date”). The Company is permitted, subject to certain conditions specified in the Credit Agreement, to elect to have the principal of any loans outstanding on the Termination Date converted into non-revolving term loans, which shall be repaid in full on the date that is one year after the Termination Date.

The Credit Agreement contains customary representations and affirmative and negative covenants. The financial covenant in the Credit Agreement requires the Company to maintain, as of the last day of any fiscal quarter, a Consolidated Net Leverage Ratio, as such term is defined in the Credit Agreement and subject to certain conditions contained therein, of no greater than 3.75 to 1.00. The Credit Agreement also contains customary events of default (including non-payment of principal or interest and breaches of covenants). This revolving credit facility may be used for general corporate purposes and backs the Company's commercial paper program.

The descriptions of the provisions of the Credit Agreement are summary in nature and are qualified in their entirety by reference to the full and complete terms of the Credit Agreement, which is filed herewith as Exhibit 10.1.

Certain of the financial institutions party to the Credit Agreement and the Issuing and Paying Agency Agreement or their respective affiliates, and the dealers under the Company’s commercial paper program, have performed and may in the future perform various lending, commercial banking, investment banking, financial advisory, securitization, trustee or other services for the Company. The Company pays these financial institutions customary fees and expenses for these services.

Item 9.01: Financial Statements and Exhibits

(d) Exhibits

Exhibit Number			Exhibit Description
10.1			364-Day Credit Agreement, dated October 7, 2025
104			Cover Page Interactive Data File (embedded within the Inline XBRL document)

2

Signatures

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Cardinal Health, Inc.

(Registrant)

Date:

October 10, 2025

By:

/s/ AARON E. ALT

Aaron E. Alt

Chief Financial Officer

3